Anti-human FLT3 monoclonal antibody that inhibits proliferation of monocytic leukemia cell line SHI-1

Hybridoma

Volumn 30, Issue 1, 2011, Pages 61-67

  Ju, Songguang ^a   Xue, Zhimou ^a   Ju, Songwen ^a   Ge, Yan ^a   Xie, Wei ^a   Zhu, Huanting ^a   Pan, Jianzhong ^a   Zhang, Xueguang ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 10G6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ANTIGENICITY; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; IMMUNIZATION; IMMUNOTHERAPY; IN VITRO STUDY; LEUKEMIA CELL LINE; MONOCYTIC LEUKEMIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TARGET CELL;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; FMS-LIKE TYROSINE KINASE 3; HUMANS; LEUKEMIA; MONOCYTES;

EID: 79952305443     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2010.0073     Document Type: Article

References (24)

1. Mathews W, Jordan CT, Wiegand GW, Pardoll D, and Lemischka IR: A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell enriched populations. Cell 1991;65:1143-1152. (Pubitemid 121001328)
2. Rosnet O, Marchetto S, deLapeyriere O, and Birnbaum D: Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. Oncogene 1991;6:1641-1650. (Pubitemid 21924268)
3. Rosnet O, Mattei MG, Marchetto S, and Birnbaum D: Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics 1991;9:380-385.
4. Maroc N, Rottapel R, Rosnet O, Marchetto S, Lavezzi C, Mannoni P, Birnbaum D, and Dubreuil P: Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase. Oncogene 1993;8:909-918. (Pubitemid 23087422)
5. Lyman SD, James L, Zappone J, Sleath PR, Beckmann MP, and Bird T: Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene. Oncogene 1993;8:815-822. (Pubitemid 23087411)
6. Lyman SD, James L, Vanden Bos T, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FA, Maraskovsky E, Farrah T, Foxworth T, Williams DE, and Beckman MP: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993;75:1157-1167. (Pubitemid 24006112)
7. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon D, Shanafelt A, Muench M, Kelner G, Namikawa R, Rennick D, Roncarolo MG, Zlotnik A, Rosnet O, Dubreuil P, Birnbaum D, and Lee F: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 1994;368:643-648. (Pubitemid 24153389)
8. Savvides SN, Boone T, and Andrew KP: Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots. Nat Struct Biol 2000;7:486-491. (Pubitemid 30414471)
9. Lyman SD, Stocking K, Davison B, Fletcher F, Johnson L, and Escobar S: Structural analysis of human and murine flt3 ligand genomic loci. Oncogene 1995;11:1165-1172.
10. Lyman SD: Biology of flt3 ligand and receptor. Int J Hematol 1995;62:63-73.
11. Ray RJ, Paige CJ, Furlonger C, Lyman SD, and Rottapel R: Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin-11 and interleukin-7. Eur J Immunol 1996;26:1504-1510. (Pubitemid 26229995)
12. Ebihara Y, Tsuji K, Lyman SD, Sui X, Yoshida M, Muraoka K, Yamada K, Tanaka R, and Nakahata T: Synergistic action of Flt3 and gp130 signalings in human hematopoiesis. Blood 1997;90:4363-4368. (Pubitemid 27508442)
13. Sonoda Y, Kimura T, Sakabe H, Tanimukai S, Ohmizono Y, Nakagawa S, Yokota S, Lyman SD, and Abe T: Human FLT3 ligand acts on myeloid as well as multipotential progenitors derived from purified CD34+ blood progenitors expressing different levels of c-kit protein. Eur J Haematol 1997;58:257-264. (Pubitemid 27244136)
14. Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, and Caligiuri MA: In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol 2010;184(6):2769-2775.
15. Karsunky H, Merad M, Cozzio A, Weissman IL, and Manz MG: Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med 2003;198(2):305-313. (Pubitemid 36987855)
16. Böiers C, Buza-Vidas N, Jensen CT, Pronk CJ, Kharazi S, Wittmann L, Sitnicka E, Hultquist A, and Jacobsen SE: Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development. Blood 2010;115(24):5061-5068.
17. Zheng R, Levis M, Piloto O, Brown P, Baldwin BR, Gorin NC, Beran M, Zhu Z, Ludwig D, Hicklin D, Witte L, Li Y, and Small D: FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells. Blood 2004;103(1):267-274. (Pubitemid 38029948)
18. Pratz KW, and Levis MJ: Bench to bedside targeting of FLT3 in acute leukemia. Curr Drug Targets 2010;11(7):781-789.
19. Chen S, Xue Y, Zhang X, Wu Y, Pan J, Wang Y, and Ceng J: New human acute monocytic leukemia cell line SHI-1 with t(6;11)(q27;q23), p53 gene alterations and high tumorigenicity in nude mice. Haematologica 2005;90(6):766-775. (Pubitemid 40897218)
20. Groth SF, and Scheidegger D: Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 1980;35:1-21.
21. Small D, Levenstein M, Kim E, Carow C, Amin S, Rockwell P, Witte L, Burrow C, Ratajczak MZ, Gewirtz AM, and Civin CI: STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 1994;91:459-463. (Pubitemid 24041421)
22. Rosnet O, Buhring HJ, Marchetto S, Rappold I, Lavagna C, Sainty D, Arnoulet C, Chabannon C, Kanz L, Hannum C, and Birnbaum D: Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 1996;10:238-248. (Pubitemid 26102887)
23. Gilliland DG, and Griffin JD: The roles of FLT3 in hematopoiesis and leukemia. Blood 2002;100(5):1532-1542.
24. Gale RE, Green C, Allen C, Mead AJ, Burnett AK, Hills RK, Linch DC; Medical Research Council Adult Leukaemia Working Party: The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Blood 2008;111(5):2776-2784.